HKD 29.52
+0.48%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenHKD 29.70
From 52W high−12.82%
Volume7.02M
Market capHKD 53.22B
P/E (TTM)26.3x
P/S (TTM)3.0x
Div yield0.78%
Key dataSep 18, 2026
Open
HKD 29.70
From 52W high
−12.82%
Volume
7.02M
Market cap
HKD 53.22B
ValuationView details →
P/E (Fwd)
16.8x
EV/EBITDA
19.7x
P/E (TTM)
26.3x
RSI (14)
54.5
MomentumView details →
1D Return
+0.48%
YTD Return
+50.69%
Similar companies
Latest newsMore news →
Pharmaceutical R&D service company Pharmaron (03759) announced the proposed issuance of RMB 2.18 billion zero-coupon convertible bonds due 2027, priced at 102% of principal, with net proceeds of approximately USD 327.2 million to be used for business expansion, debt refinancing, and general corporate purposes.25d agoAI² Robotics and Pharmaron signed a strategic partnership agreement to combine AI² Robotics' embodied large model technology with Pharmaron's life sciences expertise, focusing on deploying embodied intelligence in pharmaceutical R&D and building smart lab ecosystems.25d ago